SOPHiA GENETICS (SOPH) Capital Expenditures Growth (1y) (2021 - 2025)

SOPHiA GENETICS (SOPH) Capital Expenditures Growth (1y) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex Growth (1y) (Qtr)
1 Veeva Systems 26.11 Bn 18.79 Bn 662.02 Mn -70.37%
2 BrightSpring Health Services 12.95 Bn 12.07 Bn 482.22 Mn -64.78%
3 Healthequity 7.46 Bn 7.19 Bn 256.31 Mn 18,423.26%
4 Hinge Health 5.15 Bn 4.83 Bn 154.23 Mn -
5 Doximity 3.75 Bn 3.00 Bn 125.97 Mn 49.50%
6 10x Genomics 3.69 Bn 3.15 Bn 106.18 Mn -93.77%
7 Waystar Holding 3.61 Bn 3.45 Bn 268.04 Mn 182.47%
8 Privia Health 2.90 Bn 2.54 Bn 595.71 Mn -
9 Omnicell 1.72 Bn 1.54 Bn 140.36 Mn 1,174.08%
10 SOPHiA GENETICS 23.54 Mn -46.75 Mn 14.69 Mn -492.98%

Historic Data

Download Data
DateValue
Dec 31, 2025 -492.98%
Sep 30, 2025 -39.47%
Jun 30, 2025 11,058.33%
Mar 31, 2025 -1,359.60%
Dec 31, 2024 54.40%
Sep 30, 2024 38.21%
Jun 30, 2024 98.37%
Mar 31, 2024 80.51%
Dec 31, 2023 93.49%
Sep 30, 2023 86.48%
Jun 30, 2023 -4.68%
Mar 31, 2023 9.45%
Dec 31, 2022 -1,172.19%
Sep 30, 2022 29.29%
Jun 30, 2022 39.95%
Mar 31, 2022 -690.14%
Dec 31, 2021 16.11%
Sep 30, 2021 -1,396.51%